---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-110816"
form_type: "8-K"
ticker: "SMNR"
cik: "0001913577"
company_name: "Semnur Pharmaceuticals, Inc."
filed_at: "2026-03-17T23:59:59+00:00"
generated_at: "2026-05-15T10:59:18.032890+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# CEO Jaisim Shah retires; Henry Ji appointed CEO and President; Stephen Ma named COO

## Summary
- Jaisim Shah resigned as CEO, President, and director effective March 13, 2026; retirement not due to any disagreement.
- Henry Ji (age 61), formerly Executive Chairperson, appointed CEO and President; also CEO of Scilex (SCLX) and Vivasor.
- Stephen Ma, previously CFO and Secretary, appointed COO effective March 17, 2026; also COO of Scilex.
- Shah receives six months base salary ($1,250,000/yr) and 90-day extension to exercise vested stock options per separation agreement.
- Board size reduced from six to five directors following Shah's resignation.

## SEC filing metadata
- accession: 0001193125-26-110816
- form_type: 8-K
- ticker: SMNR
- cik: 0001913577
- company_name: Semnur Pharmaceuticals, Inc.
- filed_at: 2026-03-17T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.75
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1913577/000119312526110816/0001193125-26-110816-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1913577/000119312526110816/smnr-20260313.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-110816
- JSON: https://secwatch.observer/filing/0001193125-26-110816.json
- Plain text: https://secwatch.observer/filing/0001193125-26-110816.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.